Drug delivery deal is where the music is currently and Rohan emphasised that the distinct difference between the US biotech investor market and our own is for financial commitments to occur in US based entities to concentrate on the data in contrast to our domestic landscape being preoccupied with overseas partnership commitments providing validation of the tech.
Rohan’s long term strategy might be unfolding well, it is all in the data and the mentioning of glaucoma is of particular interest, all IMO
Drug delivery deal is where the music is currently and Rohan...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.015(1.33%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $129.6K | 114.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 325 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 4783 | 3 |
View Market Depth
| Last trade - 15.06pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |